[13C6]-Ripretinib

Catalog Number	ACMA00065224
Description	Ripretinib is intended for Pharmaceuticals applications, it acts as a Tyrosine Kinase Inhibitor used for the treatment of advanced gastrointestinal stromal tumor (GIST) that has not adequately responded to other kinase inhibitors such as sunitinib and imatinib. All information about [13C6]-Ripretinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis.
Synonyms	[13C6]-Qinlock, [13C6]-DCC 2618, [13C6]-DP 2618, [13C6]-1-[4-Bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea
Molecular Weight	516.32
Molecular Formula	C24H21BrFN5O2
Purity	≥95%
Isotopic Enrichment	99% 13C
Stability	≥1 year
Unlabeled CAS	1442472-39-0

Please kindly note that our products and services are for research use only.

Online Inquiry



mg g kg ml L

[13C6]-Ripretinib (ACMA00065224)

SUBMIT